Safety in pharmaceutical industry including microbiological, chemical, equipment safety, and other safety elements.
Adverse effects in clinical trials are not just for clinical research teams. They are relevant to everyone working in the pharmaceutical industry, including QA, QC, Production, R&D, Microbiology, Regulatory Affairs, and Pharmacovigilance. Even if you never work directly on clinical trials, understanding these terms helps you appreciate how drug safety is evaluated before a product ever reaches manufacturing or the market. This article explains adverse effects in simple terms, while still aligning with ICH guidelines. Why Are Adverse Effects So Important…
In pharmaceutical manufacturing, controlling contamination is crucial for obtaining reliable results and ensuring product safety. Two essential pieces of equipment widely used to maintain sterile working conditions are Laminar Airflow Cabinets and Biosafety Cabinets. They may appear similar at first glance, but they serve distinct purposes and offer different levels of protection to the sample, the operator, and the environment. Let’s explore the fundamental concepts behind laminar airflow cabinets and biosafety cabinets, their mechanisms of action, detailed classifications, and typical applications.…
Biosafety levels in Microbiology are established to safely handle the microorganisms in the laboratory. The primary objective is to minimize the risks associated with working with various microbes. The microbes may range from harmless to highly infectious pathogens. The concept of biosafety levels was developed to standardize the safety measures. This classification system, ranging from Biosafety Level 1 (BSL-1) to Biosafety Level 4 (BSL-4), allows laboratories to design their safety protocols based on the specific characteristics of the microorganisms they are…
